Search

Search Constraints

You searched for: Author/Creator Fulcher, Greg

Search Results

1. Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program. Issue 5 (31st July 2018)

2. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials. Issue 9 (September 2018)

3. Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results From the Randomized CANVAS Program Trials. Issue 2 (February 2019)

4. Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study). Issue 4 (23rd January 2018)

5. Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program. Issue 3 (13th March 2021)

6. Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program. Issue 15 (9th October 2018)

7. Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial. Issue 4 (7th April 2021)

8. FP484DIFFERENT eGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM. (13th June 2019)

9. Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study. Issue 1 (6th January 2020)

10. Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study. Issue 1 (6th January 2020)